Our data suggest that maternal HFD is associated with epigenetic alterations in EphB2, VWF, Ppargc1β and Fgf21 that may contribute to the pathogenesis of NASH. The gene discussed is EPHB2; the disease is metabolic dysfunction-associated steatohepatitis.